Yasemin Soysal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yasemin Soysal has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ezgi Nur Çil
Institute of Health Sciences, Department of Molecular Medicine, Dokuz Eylül University, 35340 İzmir, Türkiye
4 shared publications A. U. Ural
Hematology
1 shared publication- Avni Atay
Yeni Yüzyıl University Faculty of Medicine, Gaziosmanpaşa Hospital, Department of Pediatric Hematology/Oncology and Pediatric BMT Unit, İstanbul, Türkiye
1 shared publication - Ayten Darcan
Institute of Health Sciences, Department of Molecular Medicine, Dokuz Eylül University, 35340 İzmir, Türkiye
1 shared publication - Bedri Beydemir
University of Health Sciences
1 shared publication - Fadime Mutlu Icduygu
Department of Medical Genetics, Faculty of Medicine, Giresun University, Giresun, Turkey
1 shared publication
Latest Publications
- 30 September 2026
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 10 (3) , 397-402
Concentration-Dependent Inhibitory Effect Of Calcium Fructoborate On Sirt1 Enzyme Activity: A Comparative Analysis With Boric Acid
Purpose: SIRT1 functions in regulatory mechanisms including cellular aging, apoptosis, glucose and lipid metabolism, oxidative stress and inflammation. Studies show that SIRT1 inhibitors may affect various types of cancer and metabolic disorders, making SIRT1 an important therapeutic target. Boric acid is an inorganic boron compound with antimicrobial, antifungal and potential anticancer effects. Calcium fructoborate, another boron compound found in vegetables and fruits, has anti-inflammatory, antioxidant and anti-tumor effects. This study aimed to investigate the inhibitory potential of calcium fructoborate on SIRT1 activity and to evaluate its possible use as a chemical tool for future studies targeting SIRT1 regulation.Material and Methods: In this study, the effect of calcium fructoborate on SIRT1 activity was investigated by a fluorescence-based method using human recombinant SIRT1.Results: Calcium fructoborate inhibited SIRT1 activity in a dose-dependent manner. Calcium fructoborate significantly inhibited SIRT1 activity by 42% at a concentration of 20 mM (p < 0.001). In the boric acid group, a decreasing trend in SIRT1 enzyme activity was observed, but this difference was not statistically significant.Conclusion: The results provide important basic information. Calcium fructoborate may be used as a chemical tool to elucidate the biological functions of SIRT1 and to investigate the potential therapeutic applications of SIRT1 inhibitors.
- 30 September 2026
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 10 (3) , 397-402
Concentration-Dependent Inhibitory Effect Of Calcium Fructoborate On Sirt1 Enzyme Activity: A Comparative Analysis With Boric Acid
Purpose: SIRT1 functions in regulatory mechanisms including cellular aging, apoptosis, glucose and lipid metabolism, oxidative stress and inflammation. Studies show that SIRT1 inhibitors may affect various types of cancer and metabolic disorders, making SIRT1 an important therapeutic target. Boric acid is an inorganic boron compound with antimicrobial, antifungal and potential anticancer effects. Calcium fructoborate, another boron compound found in vegetables and fruits, has anti-inflammatory, antioxidant and anti-tumor effects. This study aimed to investigate the inhibitory potential of calcium fructoborate on SIRT1 activity and to evaluate its possible use as a chemical tool for future studies targeting SIRT1 regulation.Material and Methods: In this study, the effect of calcium fructoborate on SIRT1 activity was investigated by a fluorescence-based method using human recombinant SIRT1.Results: Calcium fructoborate inhibited SIRT1 activity in a dose-dependent manner. Calcium fructoborate significantly inhibited SIRT1 activity by 42% at a concentration of 20 mM (p < 0.001). In the boric acid group, a decreasing trend in SIRT1 enzyme activity was observed, but this difference was not statistically significant.Conclusion: The results provide important basic information. Calcium fructoborate may be used as a chemical tool to elucidate the biological functions of SIRT1 and to investigate the potential therapeutic applications of SIRT1 inhibitors.
- Open Access
Curcumin Opposes Perfluorodecanoic Acid–Induced Adipogenesis Through the PPARγ/C/EBPα Axis in 3T3-L1 Cells
(1) Background: Perfluorodecanoic acid (PFDA), a persistent perfluoroalkyl obesogen, promotes adipogenesis, yet whether its effects can be pharmacologically opposed remains unknown. (2) Methods: We examined the interaction between PFDA (50, 75 μM) and the dietary polyphenol curcumin (20, 30 μM) throughout the 8-day 3T3-L1 preadipocyte differentiation protocol, using cell-viability (WST-1) assays with a two-factor interaction analysis, Oil Red O lipid quantification and mRNA profiling of Pparg, Cebpa, Srebf1, and Fasn. (3) Results: PFDA alone increased lipid accumulation and upregulated Pparg, Cebpa, and Fasn, whereas Srebf1 was induced only weakly and only at the higher dose, a pattern compatible with preferential engagement of the PPARγ/C/EBPα program over the SREBP-1c lipogenic pathway at the mRNA level, although the transcripts were not formally compared and no protein-level data were obtained. At two sub-cytotoxic concentrations, curcumin preserved potent antiadipogenic activity, reducing lipid accumulation by up to 67.3% and reversing PFDA-induced gene upregulation. At the viability endpoint the two compounds acted independently: curcumin significantly reduced viability and PFDA significantly increased it, with no statistically detectable interaction between them (two-way ANOVA, interaction p = 0.85). (4) Conclusions: This dissociation shows that a chemical interaction defined at one biological endpoint does not predict its outcome at another, a principle with broad implications for mixture toxicology—and it establishes curcumin as a candidate dietary intervention that intercepts an obesogen’s transcriptional program against environmentally driven metabolic disruption.
Open AccessCurcumin Opposes Perfluorodecanoic Acid–Induced Adipogenesis Through the PPARγ/C/EBPα Axis in 3T3-L1 Cells
(1) Background: Perfluorodecanoic acid (PFDA), a persistent perfluoroalkyl obesogen, promotes adipogenesis, yet whether its effects can be pharmacologically opposed remains unknown. (2) Methods: We examined the interaction between PFDA (50, 75 μM) and the dietary polyphenol curcumin (20, 30 μM) throughout the 8-day 3T3-L1 preadipocyte differentiation protocol, using cell-viability (WST-1) assays with a two-factor interaction analysis, Oil Red O lipid quantification and mRNA profiling of Pparg, Cebpa, Srebf1, and Fasn. (3) Results: PFDA alone increased lipid accumulation and upregulated Pparg, Cebpa, and Fasn, whereas Srebf1 was induced only weakly and only at the higher dose, a pattern compatible with preferential engagement of the PPARγ/C/EBPα program over the SREBP-1c lipogenic pathway at the mRNA level, although the transcripts were not formally compared and no protein-level data were obtained. At two sub-cytotoxic concentrations, curcumin preserved potent antiadipogenic activity, reducing lipid accumulation by up to 67.3% and reversing PFDA-induced gene upregulation. At the viability endpoint the two compounds acted independently: curcumin significantly reduced viability and PFDA significantly increased it, with no statistically detectable interaction between them (two-way ANOVA, interaction p = 0.85). (4) Conclusions: This dissociation shows that a chemical interaction defined at one biological endpoint does not predict its outcome at another, a principle with broad implications for mixture toxicology—and it establishes curcumin as a candidate dietary intervention that intercepts an obesogen’s transcriptional program against environmentally driven metabolic disruption.
- Open Access
- 6 April 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (6) , 2544-2554
Programmed Cell Death 1 (PDCD1) Gene Polymorphisms in Patients with Ankylosing Spondylitis: A Turkish Case–Control Study
Objective: The inflammatory process resulting from the autoimmune response has a fundamental role in the pathogenesis of ankylosing spondylitis (AS). The PDCD1 gene regulates the immune system and may play a role in the pathogenesis of autoimmune diseases. In this study, we aimed to investigate the role of single-nucleotide polymorphisms (SNPs) within the PDCD1 gene and their corresponding haplotypes as potential biomarkers for susceptibility to AS in Turkish patients. Materials and Methods: A total of 150 AS patients and 144 healthy individuals were examined for the genotypes of PD-1.1, PD-1.3, PD-1.5, and PD-1.9 SNPs using the method of PCR–RFLP from peripheral blood DNA extracts. Results: Regarding the genotype frequencies of PD-1.1 ( p = 0.952), PD-1.3 ( p = 0.106), PD-1.5 ( p = 0.653), and PD-1.9 ( p = 0.994) polymorphisms, no significant difference was found between patients with AS and controls. Conclusion: The PDCD1 gene plays a crucial role in the T cell activation’s negative regulation of peripheral tolerance. Population-based differences have been reported in the PDCD1 gene polymorphism. Our study presents data on PDCD1 gene polymorphism for the first time in a Turkish cohort of ankylosing spondylitis patients and discusses the role of this gene as a biomarker for AS disease pathogenesis.
- 6 April 2026
- Published by Springer Nature in Bratislava Medical Journal
- Vol. 127 (6) , 2544-2554
Open AccessProgrammed Cell Death 1 (PDCD1) Gene Polymorphisms in Patients with Ankylosing Spondylitis: A Turkish Case–Control Study
Objective: The inflammatory process resulting from the autoimmune response has a fundamental role in the pathogenesis of ankylosing spondylitis (AS). The PDCD1 gene regulates the immune system and may play a role in the pathogenesis of autoimmune diseases. In this study, we aimed to investigate the role of single-nucleotide polymorphisms (SNPs) within the PDCD1 gene and their corresponding haplotypes as potential biomarkers for susceptibility to AS in Turkish patients. Materials and Methods: A total of 150 AS patients and 144 healthy individuals were examined for the genotypes of PD-1.1, PD-1.3, PD-1.5, and PD-1.9 SNPs using the method of PCR–RFLP from peripheral blood DNA extracts. Results: Regarding the genotype frequencies of PD-1.1 ( p = 0.952), PD-1.3 ( p = 0.106), PD-1.5 ( p = 0.653), and PD-1.9 ( p = 0.994) polymorphisms, no significant difference was found between patients with AS and controls. Conclusion: The PDCD1 gene plays a crucial role in the T cell activation’s negative regulation of peripheral tolerance. Population-based differences have been reported in the PDCD1 gene polymorphism. Our study presents data on PDCD1 gene polymorphism for the first time in a Turkish cohort of ankylosing spondylitis patients and discusses the role of this gene as a biomarker for AS disease pathogenesis.
- 12 November 2024
- Published by Springer Nature in Biological Trace Element Research
- Vol. 203 (7) , 3833-3844
Anti-Obesity Effects of Calcium Fructoborate by Inhibiting Adipogenesis and Increasing SIRT’s Expression in 3T3-L1 Cells
Obesity is a global public health problem that can lead to mortality and morbidity. Studies on the pathophysiology of obesity for effective and safe treatments are focused on the mechanisms of adipogenesis. The association between boron treatment and weight loss has been reported, but its anti-adipogenic mechanisms and effects on preadipocytes remain unclear. This study aims to investigate the effects of boron compounds boric acid (BA) and calcium fructoborate (CaFB) on adipogenesis using the most widely used in vitro 3T3-L1 cellular model. In our study, cytotoxicity, Oil Red O (ORO), gene and protein expression analyses and cellular NAD measurements of boron compounds were performed. Peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) transcription factors are the main regulators of adipogenesis, and boron compounds affect them at gene and protein levels by showing anti-obesity effects. This is the first study to show that CaFB has anti-obesity properties in mouse adipocytes. Sirtuins, known as the longevity genes, were also activated from boron treatment. Results of this research provide new basic knowledge and insights into the effect of boron-based compounds on obesity. It also offers potential prospects for the development of effective treatment and/or supportive treatment methods.
- 12 November 2024
- Published by Springer Nature in Biological Trace Element Research
- Vol. 203 (7) , 3833-3844
Anti-Obesity Effects of Calcium Fructoborate by Inhibiting Adipogenesis and Increasing SIRT’s Expression in 3T3-L1 Cells
Obesity is a global public health problem that can lead to mortality and morbidity. Studies on the pathophysiology of obesity for effective and safe treatments are focused on the mechanisms of adipogenesis. The association between boron treatment and weight loss has been reported, but its anti-adipogenic mechanisms and effects on preadipocytes remain unclear. This study aims to investigate the effects of boron compounds boric acid (BA) and calcium fructoborate (CaFB) on adipogenesis using the most widely used in vitro 3T3-L1 cellular model. In our study, cytotoxicity, Oil Red O (ORO), gene and protein expression analyses and cellular NAD measurements of boron compounds were performed. Peroxisome proliferator-activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) transcription factors are the main regulators of adipogenesis, and boron compounds affect them at gene and protein levels by showing anti-obesity effects. This is the first study to show that CaFB has anti-obesity properties in mouse adipocytes. Sirtuins, known as the longevity genes, were also activated from boron treatment. Results of this research provide new basic knowledge and insights into the effect of boron-based compounds on obesity. It also offers potential prospects for the development of effective treatment and/or supportive treatment methods.
- Open Access
- 29 April 2024
- Published by Bulent Evcevit University in Turkish Journal of Diabetes and Obesity
- Vol. 8 (1) , 59-64
Obezite Araştırmaları İçin İn Vitro Adiposit Hücre Kültürü İle Etkili Model Oluşturma: Ön Çalışma
Türkiye Diyabet ve Obezite Dergisi | Cilt: 8 Sayı: 1
- 29 April 2024
- Published by Bulent Evcevit University in Turkish Journal of Diabetes and Obesity
- Vol. 8 (1) , 59-64
Open AccessObezite Araştırmaları İçin İn Vitro Adiposit Hücre Kültürü İle Etkili Model Oluşturma: Ön Çalışma
Türkiye Diyabet ve Obezite Dergisi | Cilt: 8 Sayı: 1
- 23 June 2005
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 32 (7) , 511-517
In vitro IL‐1β release from gingival fibroblasts in response to pure metals, dental alloys and ceramic
Little information is available on the immunological basis for side-effects of dental materials. The objective of this study is to evaluate effects of pure metals, dental alloys and ceramic on cell viability and interleukin-1 beta (IL-1beta) release in three-dimensional human gingival fibroblast cultures as an indicator of their biological performance in gingival tissues. The gingival fibroblast cultures were exposed to test specimens fabricated from nickel, iron, molybdenum, copper, indium, gold, Ni-Cr-Mo alloy (Remanium CS), Au-Pt-In alloy (Pontostar) and a dental ceramic (In-ceram). Cell viability was determined by the MTT method 24 and 48 h after exposure. Assays for IL-1beta were carried out by ELISA. Statistical analysis was performed applying the non-parametric Mann-Whitney pairwise test. Dental ceramic and gold did not influence cell viability after 24 and 48 h. Cell viability was determined after 24 and 48 h to nickel (79-77%), iron (92-90%), molybdenum (86-83%), copper (48-36%), indium (90-90%), Remanium CS (83-80%), Pontostar (94-91%) compared with control cultures. Dental ceramic, Pontostar and gold had no significant influence on IL-1beta secretion. The highest amounts of IL-1beta (10-fold) levels were determined in cell cultures exposed to copper. Indium, molybdenum and iron induced twofold IL-1beta levels compared with untreated control cultures. These results support that some metals may alter immune responses and thereby contribute to a variety of dental pathological conditions and three-dimensional cell culture models for gingival fibroblasts appear to be suitable for in vitro studies.
- 23 June 2005
- Published by Wiley in Journal of Oral Rehabilitation
- Vol. 32 (7) , 511-517
In vitro IL‐1β release from gingival fibroblasts in response to pure metals, dental alloys and ceramic
Little information is available on the immunological basis for side-effects of dental materials. The objective of this study is to evaluate effects of pure metals, dental alloys and ceramic on cell viability and interleukin-1 beta (IL-1beta) release in three-dimensional human gingival fibroblast cultures as an indicator of their biological performance in gingival tissues. The gingival fibroblast cultures were exposed to test specimens fabricated from nickel, iron, molybdenum, copper, indium, gold, Ni-Cr-Mo alloy (Remanium CS), Au-Pt-In alloy (Pontostar) and a dental ceramic (In-ceram). Cell viability was determined by the MTT method 24 and 48 h after exposure. Assays for IL-1beta were carried out by ELISA. Statistical analysis was performed applying the non-parametric Mann-Whitney pairwise test. Dental ceramic and gold did not influence cell viability after 24 and 48 h. Cell viability was determined after 24 and 48 h to nickel (79-77%), iron (92-90%), molybdenum (86-83%), copper (48-36%), indium (90-90%), Remanium CS (83-80%), Pontostar (94-91%) compared with control cultures. Dental ceramic, Pontostar and gold had no significant influence on IL-1beta secretion. The highest amounts of IL-1beta (10-fold) levels were determined in cell cultures exposed to copper. Indium, molybdenum and iron induced twofold IL-1beta levels compared with untreated control cultures. These results support that some metals may alter immune responses and thereby contribute to a variety of dental pathological conditions and three-dimensional cell culture models for gingival fibroblasts appear to be suitable for in vitro studies.